Tirzepatide L-isoAsp15 Impurity Reference Standard Package Size:50mg Jul 2008] Swissprot No P22033

Jul 2008] Swissprot No P22033 Gene Accession 4594 WB Predicted band size 83 kDa WB Positive control WB Recommended dilution 500-2000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human cholangiocarcinoma IHC Recommed dilution Recommended dilution: 50-100 Storage

Fixed speed: 3000rpm

Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue using P290305(CLEC3B Antibody) at dilution 1/50

heating temperature up to 550°C

Tirzepatide L-isoAsp15 Impurity Reference Standard Package Size:50mg Jul 2008] Swissprot No P22033Description Tirzepatide L isoAsp15 impurity is a high purity impurity reference standard used for pharmaceutical quality control, analytical method development, and regulatory compliance testing of Tirzepatide, a GLP 1 GIP dual receptor agonist. This product is part of Biofargo's Tirzepatide Impurity Reference Standards portfolio. Isoaspartate formation at position 15 is a well documented degradation pathway in peptide drugs that may affect structural